1
|
Kennedy S, Bergqvist A, Chapron C,
D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A and
Saridogan E; ESHRE Special Interest Group for Endometriosis and
Endometrium Guideline Development Group, : ESHRE guideline for the
diagnosis and treatment of endometriosis. Hum Reprod. 20:2698–2704.
2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Eskenazi B and Warner ML: Epidemiology of
endometriosis. Obstet Gynecol Clin North Am. 24:235–258. 1997.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Zondervan KT, Yudkin PL, Vessey MP,
Jenkinson CP, Dawes MG, Barlow DH and Kennedy SH: The community
prevalence of chronic pelvic pain in women and associated illness
behaviour. Br J Gen Pract. 51:541–547. 2001.PubMed/NCBI
|
4
|
Zondervan KT, Cardon LR and Kennedy SH:
What makes a good case-control study? Design issues for complex
traits such as endometriosis. Hum Reprod. 17:1415–1423. 2002.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Rogers PA, D'Hooghe TM, Fazleabas A,
Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA
and Zondervan KT: Priorities for endometriosis research:
Recommendations from an international consensus workshop. Reprod
Sci. 16:335–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Rolla E: Endometriosis: Advances and
controversies in classification, pathogenesis, diagnosis, and
treatment. F1000 Res. 8:82019. View Article : Google Scholar : PubMed/NCBI
|
7
|
Liu J, Wang Y, Chen P, Ma Y, Wang S, Tian
Y, Wang A and Wang D: AC002454.1 and CDK6 synergistically promote
endometrial cell migration and invasion in endometriosis.
Reproduction. 157:535–543. 2019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bakogiannis C, Sachse M, Stamatelopoulos K
and Stellos K: Platelet-derived chemokines in inflammation and
atherosclerosis. Cytokine. 122:1541572019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Korbecki J, Grochans S, Gutowska I,
Barczak K and Baranowska-Bosiacka I: CC Chemokines in a tumor: A
review of pro-cancer and anti-cancer properties of receptors CCR5,
CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int J Mol Sci.
21:212020. View Article : Google Scholar
|
10
|
Bian X, Xiao YT, Wu T, Yao M, Du L, Ren S
and Wang J: Microvesicles and chemokines in tumor microenvironment:
Mediators of intercellular communications in tumor progression. Mol
Cancer. 18:502019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hieshima K, Ohtani H, Shibano M, Izawa D,
Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T, et al:
CCL28 has dual roles in mucosal immunity as a chemokine with
broad-spectrum antimicrobial activity. J Immunol. 170:1452–1461.
2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Berri M, Virlogeux-Payant I, Chevaleyre C,
Melo S, Zanello G, Salmon H and Meurens F: CCL28 involvement in
mucosal tissues protection as a chemokine and as an antibacterial
peptide. Dev Comp Immunol. 44:286–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Moed H, Boorsma DM, Tensen CP, Flier J,
Jonker MJ, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ,
Rustemeyer T, et al: Increased CCL27-CCR10 expression in allergic
contact dermatitis: implications for local skin memory. Journal
Pathol. 204:39–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen L, Liu X, Zhang H-Y, Du W, Qin Z, Yao
Y, Mao Y and Zhou L: Upregulation of chemokine receptor CCR10 is
essential for glioma proliferation, invasion and patient survival.
Oncotarget. 5:6576–6583. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xiong N, Fu Y, Hu S, Xia M and Yang J:
CCR10 and its ligands in regulation of epithelial immunity and
diseases. Protein Cell. 3:571–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lin HY, Sun SM, Lu XF, Chen PY, Chen CF,
Liang WQ and Peng CY: CCR10 activation stimulates the invasion and
migration of breast cancer cells through the ERK1/2/MMP-7 signaling
pathway. Int Immunopharmacol. 51:124–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ruan F, Ma J and Zhou J: Depletion of
CCL27 inhibits cell proliferation, metastasis and adhesion in
ectopic endometrial stromal cells. Int J Clin Exp Med.
9:19074–19083. 2016.
|
18
|
Sun C, Zhang YY, Tang CL, Wang SC, Piao
HL, Tao Y, Zhu R, Du MR and Li DJ: Chemokine CCL28 induces
apoptosis of decidual stromal cells via binding CCR3/CCR10 in human
spontaneous abortion. Mol Hum Reprod. 19:676–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cha HR, Ko HJ, Kim ED, Chang SY, Seo SU,
Cuburu N, Ryu S, Kim S and Kweon MN: Mucosa-associated epithelial
chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma
cells following mucosal vaccination via estrogen control. J
Immunol. 187:3044–3052. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gentilini D, Busacca M, Di Francesco S,
Vignali M, Viganò P and Di Blasio AM: PI3K/Akt and ERK1/2
signalling pathways are involved in endometrial cell migration
induced by 17β-estradiol and growth factors. Mol Hum Reprod.
13:317–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST,
Wang YP, Hou Y, Sheng J and Sun QY: Icaritin causes sustained
ERK1/2 activation and induces apoptosis in human endometrial cancer
cells. PLoS One. 6:e167812011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Banu SK, Lee J, Speights VO Jr,
Starzinski-Powitz A and Arosh JA: Selective inhibition of
prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human
endometriotic cells through suppression of ERK1/2, AKT, NFkappaB,
and β-catenin pathways and activation of intrinsic apoptotic
mechanisms. Mol Endocrinol. 23:1291–1305. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li MQ, Li HP, Meng YH, Wang Zhu XY, Mei J
and Li DJ: Chemokine CCL2 enhances survival and invasiveness of
endometrial stromal cells in an autocrine manner by activating Akt
and MAPK/Erk1/2 signal pathway. Fertil Steril. 97:919–929. 2012.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Li MQ, Shao J, Meng YH, Mei J, Wang Y, Li
H, Zhang L, Chang KK, Wang XQ, Zhu XY, et al: NME1 suppression
promotes growth, adhesion and implantation of endometrial stromal
cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic
milieu. Hum Reprod. 28:2822–2831. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yang XL, Liu KY, Lin FJ, Shi HM and Ou ZL:
CCL28 promotes breast cancer growth and metastasis through
MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncol
Rep. 38:1393–1401. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu J, Zhang Z, Liu J and Wang D: LIM
Kinase 1 Mediates estradiol effects on the phosphorylation of
Cofilin1 in eutopic endometrial stromal cells during the invasion
and proliferation of endometriosis. Reprod Sci. 26:1499–1505. 2019.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chen Q, Hang Y, Zhang T, Tan L, Li S and
Jin Y: USP10 promotes proliferation and migration and inhibits
apoptosis of endometrial stromal cells in endometriosis through
activating the Raf-1/MEK/ERK pathway. Am J Physiol Cell Physiol.
315:C863–C872. 2018. View Article : Google Scholar : PubMed/NCBI
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
29
|
Minkwitz C, Schoon HA, Zhang Q and
Schöniger S: Plasticity of endometrial epithelial and stromal
cells-A new approach towards the pathogenesis of equine
endometrosis. Reprod Domest Anim. 54:835–845. 2019. View Article : Google Scholar : PubMed/NCBI
|
30
|
Deng X, Zhang X, Li W, Feng RX, Li L, Yi
GR, Zhang XN, Yin C, Yu HY, Zhang JP, et al: Chronic Liver Injury
Induces Conversion of Biliary Epithelial Cells into Hepatocytes.
Cell Stem Cell. 23:114–122.e3. 2018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gou Y, Li X, Li P, Zhang H, Xu T, Wang H,
Wang B, Ma X, Jiang X and Zhang Z: Estrogen receptor β upregulates
CCL2 via NF-κB signaling in endometriotic stromal cells and
recruits macrophages to promote the pathogenesis of endometriosis.
Hum Reprod. 34:646–658. 2019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Mei J, Zhou WJ, Li SY, Li MQ and Sun HX:
Interleukin-22 secreted by ectopic endometrial stromal cells and
natural killer cells promotes the recruitment of macrophages
through promoting CCL2 secretion. Am J Reprod Immunol.
82:e131662019. View Article : Google Scholar : PubMed/NCBI
|
33
|
Hirata T, Osuga Y, Takamura M, Kodama A,
Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T, et al:
Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from
IL-1 β-, TNF-α-, and IL-17A-stimulated endometriotic stromal cells.
Endocrinology. 151:5468–5476. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Guo P, Bi K, Lu Z, Wang K, Xu Y, Wu H, Cao
Y and Jiang H: CCR5/CCR5 ligand-induced myeloid-derived suppressor
cells are related to the progression of endometriosis. Reprod
Biomed Online. 39:704–711. 2019. View Article : Google Scholar : PubMed/NCBI
|
35
|
Jaiswal U, Yadav RK, Bhat MA, Kriplani A,
Roy KK and Netam RK: Cytokine and growth factor profile in
endometriosis: a multiplex analysis of peritoneal fluid to assess
diagnostic utility. Gynecol Endocrinol. 36:718–722. 2020.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Rashidiani S, Jalili A, Babaei E,
Sheikhesmaeili F, Fakhari S, Ataee P and Parhizkar B: The chemokine
CCL28 is elevated in the serum of patients with celiac disease and
decreased after treatment. Am J Clin Exp Immunol. 6:60–65.
2017.PubMed/NCBI
|
37
|
Sanaei MJ, Shirzad H, Soltani A,
Abdollahpour-Alitappeh M, Shafigh MH, Rahimian G, Mirzaei Y and
Bagheri N: Up-regulated CCL18, CCL28 and CXCL13 expression is
associated with the risk of gastritis and peptic ulcer disease in
Helicobacter pylori infection. Am J Med Sci. 361:43–54. 2021.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Lv Y, Zhao X, Zhu L, Li S, Xiao Q, He W
and Yin L: Targeting intracellular MMPs efficiently inhibits tumor
metastasis and angiogenesis. Theranostics. 8:2830–2845. 2018.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018. View Article : Google Scholar : PubMed/NCBI
|
40
|
Farina P, Tabouret E, Lehmann P, Barrie M,
Petrirena G, Campello C, Boucard C, Graillon T, Girard N and Chinot
O: Relationship between magnetic resonance imaging characteristics
and plasmatic levels of MMP2 and MMP9 in patients with recurrent
high-grade gliomas treated by Bevacizumab and Irinotecan. J
Neurooncol. 132:433–437. 2017. View Article : Google Scholar : PubMed/NCBI
|
41
|
Pino M, Galleguillos C, Torres M, Sovino
H, Fuentes A, Boric MA and Johnson MC: Association between MMP1 and
MMP9 activities and ICAM1 cleavage induced by TNF in stromal cell
cultures from eutopic endometria of women with endometriosis.
Reproduction. 138:837–847. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Aglund K, Rauvala M, Puistola U, Angström
T, Turpeenniemi-Hujanen T, Zackrisson B and Stendahl U: Gelatinases
A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to
the grade and the stage. Gynecol Oncol. 94:699–704. 2004.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Honkavuori M, Talvensaari-Mattila A, Soini
Y, Turpeenniemi-Hujanen T and Santala M: MMP-2 expression
associates with CA 125 and clinical course in endometrial
carcinoma. Gynecol Oncol. 104:217–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
44
|
Barbe AM, Berbets AM, Davydenko IS, Koval
HD, Yuzko VO and Yuzko OM: Expression and significance of matrix
metalloproteinase-2 and matrix metalloproteinas-9 in Endometriosis.
J Med Life. 13:314–320. 2020.PubMed/NCBI
|
45
|
Freitas S, Meduri G, Le Nestour E, Bausero
P and Perrot-Applanat M: Expression of metalloproteinases and their
inhibitors in blood vessels in human endometrium. Biol Reprod.
61:1070–1082. 1999. View Article : Google Scholar : PubMed/NCBI
|
46
|
Yoshiji H, Harris SR, Raso E, Gomez DE,
Lindsay CK, Shibuya M, Sinha CC and Thorgeirsson UP: Mammary
carcinoma cells over-expressing tissue inhibitor of
metalloproteinases-1 show enhanced vascular endothelial growth
factor expression. Int J Cancer. 75:81–87. 1998. View Article : Google Scholar : PubMed/NCBI
|
47
|
Kodarahmian M, Amidi F, Moini A, Kashani
L, Nashtaei MS, Pazhohan A, Bahramrezai M, Berenjian S and Sobhani
A: The modulating effects of resveratrol on the expression of MMP-2
and MMP-9 in endometriosis women: A randomized exploratory trial.
Gynecol Endocrinol. 35:719–726. 2019. View Article : Google Scholar : PubMed/NCBI
|
48
|
Shan B, Li W, Yang SY and Li ZR: Estrogen
up-regulates MMP2/9 expression in endometrial epithelial cell via
VEGF-ERK1/2 pathway. Asian Pac J Trop Med. 6:826–830. 2013.
View Article : Google Scholar : PubMed/NCBI
|
49
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long non-coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie
K, Li J, Liu R, Zhang T, Xie N, et al: Proteomics identification of
ITGB3 as a key regulator in reactive oxygen species-induced
migration and invasion of colorectal cancer cells. Mol Cell
Proteomics. May 27–2011.(Epub ahead of print). doi:
10.1074/mcp.M110.005397. View Article : Google Scholar
|
51
|
Chen J, Gu L, Ni J, Hu P, Hu K and Shi YL:
MiR-183 regulates ITGB1P expression and promotes invasion of
endometrial stromal cells. Biomed Res Int.
2015:3402182015.PubMed/NCBI
|